Previous Close | 0.5225 |
Open | 0.5225 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.5225 - 0.5225 |
52 Week Range | 0.0004 - 1.9017 |
Volume | |
Avg. Volume | 392 |
Market Cap | 83.41B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.3570 |
Earnings Date | Nov 29, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that, in partnership with The COPD Foundation ("COPDF"), MDBriefcase Group Inc. ("MDBriefCase"), a Think subsidiary, will deliver an educational series for healthcare practitioners regarding Chronic Obstructive Pulmonary Disease ("COPD") and its treatment, including the role of nebulized therapy in the mana
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that, MDBriefcase Group Inc., (MDBriefCase) a Think subsidiary, has been chosen by a global pharmaceutical company to deliver high-quality content to healthcare practitioners and allied health professionals regarding its drug and vaccine therapies. MDBriefCase will deliver programming under the contract thr
Vancouver, British Columbia--(Newsfile Corp. - May 11, 2022) - Beedie Investments Limited (the "Beedie") has entered into a credit agreement dated April 22, 2022 (the "Credit Agreement") with Think Research Corporation ("Think Research") pursuant to which Beedie has agreed to loan up to $25 million (the "Loan Facility") to Think Research. The Loan Facility will be funded by way of an initial advance of $10 million (the "Initial Advance") on the closing ...